$97.17
0.800.83%
SANDOZ GROUP AG S/ADR by Sandoz Group AG (SDZNY) Stock Price, Quote, News & History
SDZNYOTCQX
Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.
You can purchase shares of SANDOZ GROUP AG S/ADR by Sandoz Group AG (OTCQX:SDZNY) through any online brokerage.
There are no as such competitors for SANDOZ GROUP AG S/ADR by Sandoz Group AG.
There is no analysis for SANDOZ GROUP AG S/ADR by Sandoz Group AG to provide a consensus price target.
The stock price for SANDOZ GROUP AG S/ADR by Sandoz Group AG (OTCQX: SDZNY) is $ last updated .
There are no upcoming dividends for SANDOZ GROUP AG S/ADR by Sandoz Group AG.
SANDOZ GROUP AG S/ADR by Sandoz Group AG does not have any upcoming earnings scheduled.
There is no upcoming split for SANDOZ GROUP AG S/ADR by Sandoz Group AG.
SANDOZ GROUP AG S/ADR by Sandoz Group AG is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules...
